Zdrowie i gospodarka · 27/08/2015
FDA Announces Final Guidance for Shedding Studies in Gene Therapy and Oncolytic Products
The FDA has released a final guidance document outlining recommendations for sponsors of gene therapy and oncolytic virus or bacteria products to conduct shedding studies during preclinical and clinical development.
Source: Federal Register — Food and Drug AdministrationOpen original release →